NVCR Historical Earnings image   This NVCR historical earnings page last updated 10/31/2022
NVCR Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202210/27/20220.13B
Q2 20227/28/20220.14B
Q1 20224/28/20220.14B
Q4 20212/24/20220.13B
Q3 202110/28/20210.13B
Q2 20217/29/20210.13B
Q1 20214/29/20210.13B
Q4 20202/25/20210.14B
Q3 202010/29/20200.13B
Q2 20207/30/20200.12B
Q1 20204/30/20200.10B
Q4 20192/27/20200.10B
Q3 201910/31/20190.09B
Q2 20197/25/20190.09B
Q1 20195/2/20190.07B
Q4 20182/28/201969.67M
Q3 201810/25/201864.76M
Q2 20187/26/201861.51M
Q1 20184/26/201852.12M
Q4 20172/22/201853.66M
Q3 201710/26/201750.11M
Q2 20177/27/201738.38M
Q1 20174/27/201734.88M
Q4 20162/23/201730.24M
Q3 201611/2/201621.67M
Q2 20167/28/201617.92M
Q1 20165/9/201613.05M
Q4 20152/29/201612.38M
Q3 201510/26/20158.95M
NVCR Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202210/27/2022-0.250
Q2 20227/28/2022-0.230
Q1 20224/28/2022-0.040
Q4 20212/24/2022-0.250
Q3 202110/28/2021-0.130
Q2 20217/29/2021-0.140
Q1 20214/29/2021-0.040
Q4 20202/25/20210.040
Q3 202010/29/20200.090
Q2 20207/30/20200.020
Q1 20204/30/20200.040
Q4 20192/27/20200.040
Q3 201910/31/20190.020
Q2 20197/25/2019-0.010
Q1 20195/2/2019-0.130
Q4 20182/28/2019-0.17
Q3 201810/25/2018-0.13
Q2 20187/26/2018-0.17
Q1 20184/26/2018-0.23
Q4 20172/22/2018-0.12
Q3 201710/26/2017-0.13
Q2 20177/27/2017-0.24
Q1 20174/27/2017-0.21
Q4 20162/23/2017-0.26
Q3 201611/2/2016-0.39
Q2 20167/28/2016-0.48
Q1 20165/9/2016-0.42
Q4 20152/29/20162.54
Q3 201510/26/2015-2.09
Quotes delayed 20 minutes

Email EnvelopeFree NVCR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NovoCure (NVCR) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NVTS Historical Earnings
OCDX Historical Earnings
OPAD Historical Earnings
OPFI Historical Earnings
ORGN Historical Earnings
OWLT Historical Earnings
OXBR Historical Earnings
PEAR Historical Earnings
PIII Historical Earnings
PL Historical Earnings
What was the record high NVCR historical earnings result?
In terms of earnings or revenue, what is the best NVCR historical earnings result that NovoCure has ever posted, and when?

✔️Accepted answer: Within our data set, the highest NVCR historical earnings result was set in Q4 2015, when NovoCure posted results of 2.54/share. The most successful revenue quarter within our data set was Q4 2020 when NovoCure reported revenue of 0.14B.

What was the lowest NovoCure historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest NVCR has reported, and when?

✔️Accepted answer: Within our data set, the lowest NVCR historical earnings result was set in Q3 2015, when NovoCure posted results of -2.09/share. The smallest revenue quarter within our data set was Q3 2015 when NovoCure reported revenue of 8.95M.

On this page we presented the NVCR historical earnings date information for NovoCure. Reviewing that NVCR Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2015, when NVCR posted gaap of 2.54/share. Meanwhile the lowest NVCR historical earnings result was in Q3 2015, when NVCR posted gaap of -2.09/share. Moving to NovoCures historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2020 when NVCR reported 0.14B in revenue, while the smallest revenue quarter was Q3 2015 when NVCR reported 8.95M in revenue.

For self directed investors doing their due diligence on NVCR or any other given stock, their research can benefit from looking into all of the NovoCure historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into NovoCure historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for NVCR. Thanks for visiting, and the next time you need to research NVCR historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ANF shares outstanding history, Institutional Holders of CTRE, Healthcare Services Group Historical Earnings.

 

NVCR Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.